Advertisement
News
Advertisement

Bristol-Myers Squibb Releases First Quarter Sales Results By Drug

Fri, 04/30/2010 - 4:36am

First-quarter sales of Bristol-Myers Squibb Co. medicines:

 

 DRUG NAME ?USE  Q1?SALES  CHANGE?FROM?2009
 Plavix ?blood?thinner  $1.7?billion-a  up?16?percent
 Abilify ?psychiatric?disorders  $617?million?  up?5?percent
 Reyataz ?HIV?treatment  $373?million  up?16?percent
 Sustiva ?HIV?treatment  $335?million  up?15?percent
 Avapro ?high?blood?pressure  $314?million  up?4?percent
 Baraclude ?hepatitis?B?treatment  $216?million?  up?42?percent
 Orencia ?rheumatoid?arthritis  ?$169?million?  ?up?36?percent
 Erbitux ?head?and?neck?cancers  ?$166?million-a up?1?percent
 Sprycel ?chronic?myeloid?leukemia?  $131?million?  up?49?percent
 Ixempra ?breast?cancer??????????????  ?$29?million?  up?21?percent
 Onglyza ?type?2?diabetes?  $10?million?  (new?drug)
 ___

a: Revenue is split with one or more other companies.

 

Advertisement
Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading